Both in Pharmaceuticals
vTv Therapeutics vs Genelux
Over the past year VTVT returned +23.1% and GNLX returned −71.1%; their daily moves had a correlation of 0.06.
VTVT +23.1% GNLX −71.1%Growth of $1, one year, split-adjusted
| Metric | VTVT | GNLX |
|---|---|---|
| Price | $25.72 | $2.21 |
| Market cap | $101.7M | $100.0M |
| Today | 0.00% | +7.80% |
| 1 month | −14.3% | −9.8% |
| 6 months | −17.7% | −11.6% |
| Year to date | −35.7% | −49.3% |
| 1 year | — | −69.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 2.8× | 12,499.0× |
| Net cash | $86.6M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 42.9% | 70.3% |
| Short % of float | 9.7% | 12.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).